Abnormal Uterine Bleeding In Adolescents
PDF

Review

Abnormal Uterine Bleeding In Adolescents

J Clin Res Pediatr Endocrinol 2018;10(3):191-197 DOI: 10.4274/jcrpe.0014
,
PDF
Permissions

Abstract

Abnormal uterine bleeding (AUB) is the most common gynecologic complaint of adolescents admitted to hospital. Heavy menstrual bleeding (HMB) is the most frequent clinical presentation of AUB. Anovulatory cycles, owing to immature hypothalamic-pituitary-ovarian axis, is the leading etiology of HMB and there is an accompanying bleeding disorder in almost 20% of patients with HMB. Additionally, endocrine disorders such as hypothyroidism, hyperprolactinemia and polycystic ovary syndrome are possible causes of AUB. Exclusion of bleeding disorders, especially of von Willebrand disease is important for diagnosis and treatment of HMB, particularly in cases with AUB, which has been present since menarche. Management of HMB is based on the underlying etiology and severity of the bleeding. After other causes are excluded, anovulatory heavy bleeding can be treated successfully with combined oral contraceptives and iron supplementation either as an outpatient or in hospital depending on the clinical findings and level of anemia. The epidemiology, clinical presentation, diagnostic approach and treatment of HMB is discussed and our clinical experience in this field is presented in this review.

Keywords: Abnormal uterine bleeding, heavy menstrual bleeding, adolescents

Read the full text

1 section · 4 figures · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.

References

1

Munro MG, Critchley HO, Broder MS, Fraser IS; FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011;113:3-13. Epub 2011 Feb 22

2

Caufriez A. Menstrual disorders in adolescence: pathophysiology and treatment. Horm Res 1991;36:156-159.

3

ACOG Committee on Adolescent Health Care. ACOG Committee Opinion No. 349, November 2006: Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol 2006;108:1323-1328.

4

Finer LB, Philbin JM. Trends in ages at key reproductive transitions in the United States, 1951-2010. Womens Health Issues 2014;24:271-279. Epub 2014 Apr 12

5

Esen İ, Oğuz B, Serin HM. Menstrual Characteristics of Pubertal Girls: A Questionnaire-Based Study in Turkey. J Clin Res Pediatr Endocrinol 2016;8:192-196. Epub 2015 Dec 18

6

No authors listed. World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girls. II. Longitudinal study of menstrual patterns in the early postmenarcheal period, duration of bleeding episodes and menstrual cycles. World Health Organization Task Force on Adolescent Reproductive Health. J Adolesc Health Care 1986;7:236-244.

7

Flug D, Largo RH, Prader A. Menstrual patterns in adolescent Swiss girls: a longitudinal study. Ann Hum Biol 1984;11:495-508.

8

Widholm O, Kantero RL. A statistical analysis of the menstrual patterns of 8,000 Finnish girls and their mothers. Acta Obstet Gynecol Scand Suppl 1971;14:(Suppl 14):1-36.

9

Hickey M, Balen A. Menstrual disorders in adolescence: investigation and management. Hum Reprod Update 2003;9:493-504.

10

Bennett AR, Gray SH. What to do when she’s bleeding through: the recognition, evaluation, and management of abnormal uterine bleeding in adolescents. Curr Opin Pediatr 2014;26:413-419.

11

Fraser IS, Warner P, Marantos PA. Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume. Obstet Gynecol 2001;98:806-814.

12

No authors listed. ACOG Committee Opinion No. 651: Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign. Obstet Gynecol 2015;126:143-146.

13

Fraser IS, Critchley HO, Broder M, Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med 2011;29:383-390. Epub 2011 Nov 7

14

Fraser IS, Critchley HO, Munro MG, Broder M. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding? Hum Reprod 2007;22:635-643. Epub 2007 Jan 4

15

Khrouf M, Terras K. Diagnosis and Management of Formerly Called “Dysfunctional Uterine Bleeding” According to PALM-COEIN FIGO Classification and the New Guidelines. J Obstet Gynaecol India 2014;64:388-393. Epub 2014 Nov 19

16

Pecchioli Y, Oyewumi L, Allen LM, Kives S. The Utility of Routine Ultrasound in the Diagnosis and Management of Adolescents with Abnormal Uterine Bleeding. J Pediatr Adolesc Gynecol 2017;30:239-242. Epub 2016 Oct 6

17

Claessens EA, Cowell CA. Acute adolescent menorrhagia. Am J Obstet Gynecol 1981;139:277-280.

18

Lemarchand-Beraud T, Zufferey MM, Reymond M, Rey I. Maturation of the hypothalamo-pituitary-ovarian axis in adolescent girls. J Clin Endocrinol Metab 1982;54:241-246.

19

Smith YR, Quint EH, Hertzberg RB. Menorrhagia in adolescents requiring hospitalization. J Pediatr Adolesc Gynecol 1998;11:13-15.

20

Başaran HO, Akgül S, Kanbur NO, Gümrük F, Cetin M, Derman O. Dysfunctional uterine bleeding in adolescent girls and evaluation of their response to treatment. Turk J Pediatr 2013;55:186-189.

21

Oral E, Cağdaş A, Gezer A, Kaleli S, Aydin Y, Oçer F. Hematological abnormalities in adolescent menorrhagia. Arch Gynecol Obstet 2002;266:72-74.

22

Falcone T, Desjardins C, Bourque J, Granger L, Hemmings R, Quiros E. Dysfunctional uterine bleeding in adolescents. J Reprod Med 1994;39:761-764.

23

Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004;111:734-740.

24

Kanbur NO, Derman O, Kutluk T, Gürgey A. Coagulation disorders as the cause of menorrhagia in adolescents. Int J Adolesc Med Health 2004;16:183-185.

25

Díaz R, Dietrich JE, Mahoney D Jr, Yee DL, Srivaths LV. Hemostatic abnormalities in young females with heavy menstrual bleeding. J Pediatr Adolesc Gynecol 2014;27:324-329. Epub 2014 Sep 23

26

Wilkinson JP, Kadir RA. Management of abnormal uterine bleeding in adolescents. J Pediatr Adolesc Gynecol 2010;23(6 Suppl):22-30. Epub 2010 Sep 24

27

Barbieri RL. The endocrinology of the menstrual cycle. Methods Mol Biol 2014;1154:145-169.

28

Liu X, Nie J, Guo SW. Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis. Hum Reprod 2011;26:337-345. Epub 2010 Nov 28

29

Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Høyer-Hansen G, Hansson SR, Casslén B. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle. Mol Hum Reprod 2004;10:655-663. Epub 2004 Jul 8

30

Deligeoroglou E, Karountzos V, Creatsas G. Abnormal uterine bleeding and dysfunctional uterine bleeding in pediatric and adolescent gynecology. Gynecol Endocrinol 2013;29:74-78. Epub 2012 Sep 5

31

Metcalf MG, Skidmore DS, Lowry GF, Mackenzie JA. Incidence of ovulation in the years after the menarche. J Endocrinol 1983;97:213-219.

32

American College of Obstetricians and Gynecologists. ACOG committee opinion no. 557: Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol 2013;121:891-896.

33

Bradley LD, Gueye NA. The medical management of abnormal uterine bleeding in reproductive-aged women. Am J Obstet Gynecol 2016;214:31-44. Epub 2015 Aug 5

34

Demers C, Derzko C, David M, Douglas J; Society of Obstetricians and Gynaecologists of Canada. Gynaecological and obstetric management of women with inherited bleeding disorders. Int J Gynaecol Obstet 2006;95:75-87.

35

Klarmann D, Eggert C, Geisen C, Becker S, Seifried E, Klingebiel T, Kreuz W. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents. Transfusion 2010;50:1571-1580. Epub 2010 Feb 26

36

Committee on Adolescent Health Care; Committee on Gynecologic Practice. Committee Opinion No.580: von Willebrand disease in women. Obstet Gynecol 2013;122:1368-1373.

37

Rabbani LE, Seminario NA, Sciacca RR, Chen HJ, Giardina EG. Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women. J Am Coll Cardiol 2002;40:1991-1999.

38

Rajpurkar M, O’Brien SH, Haamid FW, Cooper DL, Gunawardena S, Chitlur M. Heavy Menstrual Bleeding as a Common Presenting Symptom of Rare Platelet Disorders: Illustrative Case Examples. J Pediatr Adolesc Gynecol 2016;29:537-541. Epub 2016 Feb 11

39

Gray SH. Menstrual disorders. Pediatr Rev 2013;34:6-17.

40

Hickey M, Higham JM, Fraser I. Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation. Cochrane Database Syst Rev 2012:CD001895.

41

Rimsza ME. Dysfunctional uterine bleeding. Pediatr Rev 2002;23:227-233.

42

Santos M, Hendry D, Sangi-Haghpeykar H, Dietrich JE. Retrospective review of norethindrone use in adolescents. J Pediatr Adolesc Gynecol 2014;27:41-44. Epub 2013 Dec 4

43

Cowan BD, Morrison JC. Management of abnormal genital bleeding in girls and women. N Engl J Med 1991;324:1710-1715.

44

Files JA, Ko MG, Pruthi S. Bioidentical hormone therapy. Mayo Clin Proc 2011;86673-680. Epub 2011 Apr 29

45

de Lignieres B. Oral micronized progesterone. Clin Ther 1999;21:41-60.

46

Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat 2008;107:103-111. Epub 2007 Feb 27

47

Gray SH. Abnormal vaginal bleeding in the adolescent, in Emans, Laufer, Goldstein’s Pediatric & Adolescent Gynecology. Emans SJ (ed) Lippincott Williams & Wilkins, Philadelphia, 2012:159.

48

Zreik TG, Odunsi K, Cass I, Olive DL, Sarrel P. A case of fatal pulmonary thromboembolism associated with the use of intravenous estrogen therapy. Fertil Steril 1999;71:373-375.

49

Leminen H, Hurskainen R. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health 2012;4:413-421. Epub 2012 Aug 17

50

No authors listed. Committee opinion no. 606: Options for prevention and management of heavy menstrual bleeding in adolescent patients undergoing cancer treatment. Obstet Gynecol 2014;124:397-402.